Improved Diagnostics for Mental Health Disorders
'Days, NOT Years™'
Home
About Us
Science
Pivotal Clinical Trial
Intellectual Property
Published Articles
Team
Market
Mental Health Facts
Market Potential
Partners
News
Investors
Mental Illness Help
Contact Laguna Diagnostics
News Releases
09-01-2026
-
"Blood-Based mRNA Testing for the Diagnosis of Schizophrenia and Bipolar Disorder"
.
International Biopharmaceutical Industry, Volume 9 Issue 3, page 38-40. Article published by
Richard G. Morris, PhD
, Vice President of Corporate Development.
11-15-2026
-
Laguna Diagnostics is pleased to share a recent educational feature
developed by
Christy Kestner, PhD
, a neuroscientist, neuroimmunologist, science communicator, and founder of Brain & Beyond.
Previous Press Releases
04-28-2026
-
U.S. FDA Grants Breakthrough Device Designation to Laguna Diagnostics’ mRNA Gene Biomarker Test to Aid in Differentiation of Schizophrenia and Bipolar I Disorder.
10-23-2025
-
Psychiatric Times
,
Patent Issued for Rapid Blood Tests to Differentiate Schizophrenia and Bipolar Disorder
10-01-2025
-
Laguna Diagnostics Awarded Second U.S. Patent for Rapid Blood Tests to Differentiate Schizophrenia and Bipolar Disorder, Expanding IP Portfolio in $3B Market.
05-15-2018
-
Laguna Diagnostics Announces Publication of Peer-Reviewed Study in Molecular Neuropsychiatry.
Our disruptive, rapid quantitative blood RNA gene test results are
returned to the ordering physician within
'Days, NOT Years™'
Privacy Policy
Copyright© 2017-2026 by Laguna Diagnostics, LLC
Contact Request
* Required
Comments:
Submit Request
Close